Results of a 11-year-experience with mass screening for neuroblastoma in 6-month-old infants in Japan are presented. From 11,284,837 infants who were screened, 1,400 cases of neuroblastoma were detected, an incidence of 1/ 6,500-7,500 infants by HPLC screening. Most of the cases (75%) were at stages
Neuroblastoma. Mass screening for early detection and its prognosis
โ Scribed by Tadashi Sawada; Takuro Kidowaki; Izumi Sakamoto; Tetsuo Hashida; Takafumi Matsumura; Masao Nakagawa; Tomoichi Kusunoki
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 402 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
It is apparent that mass screening at the age of six months in Japan detects significant numbers of otherwise spontaneously regressing tumors. Nishi et al. estimated that at least 50% of tumors detected by screening with the HPLC method would otherwise regress spontaneously [31]. Considering that no
Mortality resulting from neuroblastoma in birth cohorts in both Sapporo City and the whole of Japan was investigated to evaluate the effects of a high-performance liquid chromatography (HPLC) mass screening program, targeting on 6 monthold infants. In Sapporo City, the non-HPLC screened cohort showe